Cytek Biosciences Inc (CTKB)
Debt-to-assets ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 499,500 | 491,226 | 483,725 | 492,067 | 497,669 | 519,430 | 525,054 | 524,575 | 519,476 | 499,295 | 492,817 | 485,879 | 463,700 | 454,320 | 230,279 | 224,264 | 219,979 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $499,500K
= 0.00
The debt-to-assets ratio of Cytek Biosciences Inc has been consistently reported as 0.00 from December 31, 2020, to December 31, 2024. A debt-to-assets ratio of 0.00 indicates that the company has no debt in relation to its total assets during this period. This could suggest that Cytek Biosciences Inc has been operating without relying on debt financing to fund its operations and investments. It also indicates a strong financial position with all assets financed by equity or internal funds. Investors and creditors may view a low or zero debt-to-assets ratio positively as it signifies lower financial risk and potential for higher returns. However, it is essential to consider other financial ratios and factors alongside the debt-to-assets ratio to gain a comprehensive understanding of the company's financial health and performance.
Peer comparison
Dec 31, 2024